Division of Hemotology/Oncology

Chapel Hill, North Carolina 27599-2008

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-small Cell

Studies at this site

• Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung — Completed